Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing trend of pharmaceutical outsourcing
3.2.1.2 Rising technological advancements in fill-finish manufacturing processes
3.2.1.3 Increasing complexity of drug formulations
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory issues
3.2.2.2 Competition from in-house manufacturing
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Vials
5.2.1 Glass vials
5.2.2 Plastic vials
5.3 Prefilled syringes (PFS)
5.3.1 Glass PFS
5.3.2 Plastic PFS
5.4 Cartridges
5.5 Other products
Chapter 6 Market Estimates and Forecast, By Molecule, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Large molecules
6.3 Small molecules
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Biopharmaceutical companies
7.3 Pharmaceutical companies
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Boehringer Ingelheim International GmbH
9.2 Catalent Inc.
9.3 Eurofins Scientific
9.4 Fresenius Kabi Contract Manufacturing
9.5 MabPlex International Co. Ltd.
9.6 Novartis AG
9.7 Recipharm AB
9.8 Societal CDMO
9.9 Simtra BioPharma Solutions (Baxter International Inc.)
9.10 Symbiosis Pharmaceutical Services
